Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 4Active not recruiting 3Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 72Neoplasms 50Prostatic Neoplasms 36Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 25Lung Neoplasms 23Multiple Myeloma 19Head and Neck Neoplasms 19Leukemia, Myeloid, Acute 17Squamous Cell Carcinoma of Head and Neck 15Pancreatic Neoplasms 15Neoplasm Metastasis 13Carcinoma, Hepatocellular 13Stomach Neoplasms 12Recurrence 12Ovarian Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Non-Hodgkin 10Lymphoma, Follicular 10Carcinoma, Renal Cell 10Rectal Neoplasms 9Lymphoma 9Brain Neoplasms 9Sarcoma 8Melanoma 8Lymphoma, Large B-Cell, Diffuse 8Kidney Neoplasms 8Colonic Neoplasms 8Motor Activity 7Liver Neoplasms 7

Interventions

Prednisone 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms, Castration-Resistant × 30 days × Clear all
NCT05848011 2026-05-22

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

MacroGenics

Phase 2 Completed
154 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡